Leventer S M, Wulfert E, Hanin I
Neuropharmacology. 1987 Apr;26(4):361-5. doi: 10.1016/0028-3908(87)90189-4.
The time course of the cholinotoxicity of ethylcholine aziridinium ion (AF64A) has been investigated. Rats were injected with AF64A (3 nmols/3 microliters/side, bilateral, i.c.v.) or with vehicle. One day to one year after treatment, the hippocampus, cortex and striatum were analyzed for the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AchE) and high-affinity transport of choline (HAChT). In addition, the release of K+-stimulated acetylcholine (ACh) from superfused slices of hippocampus was determined. The first parameter affected was high affinity transport of choline. One day after treatment with AF64A, the high affinity transport of choline in the hippocampus was reduced by 23%. This reduction was maximal one week after treatment (-67%) and persisted for at least 6 months. The high affinity transport of choline in the striatum and cortex was not altered by treatment with AF64A. The activity of ChAT and AChE in the hippocampus was reduced by 2 days after treatment with AF64A. These deficits persisted for at least 6 months (AChE) to 1 year (ChAT). The activity of ChAT and AChE in the cortex and striatum was minimally affected up to 1 year after treatment with AF64A, at which time significant reductions were noted. The release of ACh was affected 3 days after treatment with AF64A, and remained attenuated 6 months later. These data indicate that the cholinergic deficit caused by in vivo treatment with AF64A was first apparent at the level of high affinity uptake of choline in the hippocampus HAChT. Subsequently, the activity of ChAT and AChE and release of ACh in the hippocampus were affected.(ABSTRACT TRUNCATED AT 250 WORDS)
已对氮丙啶离子乙基胆碱(AF64A)的胆碱毒性时间进程进行了研究。给大鼠双侧脑室内注射AF64A(3纳摩尔/3微升/侧)或注射溶媒。在治疗后1天至1年期间,对海马、皮质和纹状体进行分析,测定胆碱乙酰转移酶(ChAT)、乙酰胆碱酯酶(AchE)的活性以及胆碱的高亲和力转运(HAChT)。此外,还测定了海马灌流切片中钾离子刺激的乙酰胆碱(ACh)释放。首先受到影响的参数是胆碱的高亲和力转运。用AF64A治疗1天后,海马中胆碱的高亲和力转运降低了23%。这种降低在治疗后1周时最大(-67%),并持续至少6个月。用AF64A治疗后,纹状体和皮质中胆碱的高亲和力转运未发生改变。用AF64A治疗后2天,海马中ChAT和AchE的活性降低。这些缺陷持续至少6个月(AchE)至1年(ChAT)。用AF64A治疗后长达1年,皮质和纹状体中ChAT和AchE的活性受到的影响最小,此时才观察到显著降低。用AF64A治疗后3天,ACh的释放受到影响,6个月后仍减弱。这些数据表明,体内用AF64A治疗引起的胆碱能缺陷首先在海马中胆碱的高亲和力摄取水平(HAChT)上表现明显。随后,海马中ChAT和AchE的活性以及ACh的释放受到影响。(摘要截短至250字)